Although there is no evidence implicating SFKs as primary drivers of leukemia, several studies have shown high activity of Lyn in primary AML and indicated its crucial role in maintaining cell survival and proliferation of AML cells [22, 23]. This evidence concerns the gene LYN and acute myeloid leukemia.